These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients. Karaba AH; Zhu X; Benner SE; Akinde O; Eby Y; Wang KH; Saraf S; Garonzik-Wang JM; Klein SL; Bailey JR; Cox AL; Blankson JN; Durand CM; Segev DL; Werbel WA; Tobian AAR Transplantation; 2022 Apr; 106(4):835-841. PubMed ID: 35085183 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients. Hirama T; Akiba M; Shundo Y; Watanabe T; Watanabe Y; Oishi H; Niikawa H; Okada Y J Infect Chemother; 2022 Aug; 28(8):1153-1158. PubMed ID: 35599079 [TBL] [Abstract][Full Text] [Related]
4. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients. Toniutto P; Falleti E; Cmet S; Cussigh A; Veneto L; Bitetto D; Fornasiere E; Fumolo E; Fabris C; Sartor A; Peressutti R; Curcio F; Regattin L; Grillone L J Hepatol; 2022 Jul; 77(1):152-162. PubMed ID: 35283215 [TBL] [Abstract][Full Text] [Related]
5. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients. Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants. Subramanian V J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762 [TBL] [Abstract][Full Text] [Related]
7. Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort. Giannella M; Huth M; Righi E; Hasenauer J; Marconi L; Konnova A; Gupta A; Hotterbeekx A; Berkell M; Palacios-Baena ZR; Morelli MC; Tamè M; Busutti M; Potena L; Salvaterra E; ; Feltrin G; Gerosa G; Furian L; Burra P; Piano S; Cillo U; Cananzi M; Loy M; Zaza G; Onorati F; Carraro A; Gastaldon F; Nordio M; Kumar-Singh S; Baño JR; Lazzarotto T; Viale P; Tacconelli E Clin Microbiol Infect; 2023 Aug; 29(8):1084.e1-1084.e7. PubMed ID: 37150358 [TBL] [Abstract][Full Text] [Related]
8. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients. Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758 [TBL] [Abstract][Full Text] [Related]
9. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients. Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854 [TBL] [Abstract][Full Text] [Related]
10. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients. Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083 [TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients. Hamaya T; Hatakeyama S; Yoneyama T; Tobisawa Y; Kodama H; Fujita T; Murakami R; Fujita N; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Saitoh H; Narumi S; Tomita H; Ohyama C Sci Rep; 2022 Apr; 12(1):5876. PubMed ID: 35393481 [TBL] [Abstract][Full Text] [Related]
12. Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination. Chiang TP; Alejo JL; Mitchell J; Kim JD; Abedon AT; Karaba AH; Thomas L; Levan ML; Garonzik-Wang JM; Avery RK; Pekosz A; Clarke WA; Warren DS; Tobian AAR; Massie AB; Segev DL; Werbel WA Am J Transplant; 2022 Sep; 22(9):2254-2260. PubMed ID: 35429211 [TBL] [Abstract][Full Text] [Related]
13. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study. Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD; Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524 [TBL] [Abstract][Full Text] [Related]
14. Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients. Figueroa AL; Azzi JR; Eghtesad B; Priddy F; Stolman D; Siangphoe U; Leony Lasso I; de Windt E; Girard B; Zhou H; Miller JM; Das R J Infect Dis; 2024 Sep; 230(3):e591-e600. PubMed ID: 38513368 [TBL] [Abstract][Full Text] [Related]
15. Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients. Gallais F; Renaud-Picard B; Solis M; Laugel E; Soulier E; Caillard S; Kessler R; Fafi-Kremer S J Heart Lung Transplant; 2022 Oct; 41(10):1429-1439. PubMed ID: 35953352 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of the SARS-CoV-2 mRNA vaccine in lung transplant recipients: a possible trigger of rejection. Goda Y; Nakajima D; Tanaka S; Yamada Y; Yutaka Y; Unagami K; Yoshikawa M; Egawa H; Date H Gen Thorac Cardiovasc Surg; 2023 Apr; 71(4):251-257. PubMed ID: 36289168 [TBL] [Abstract][Full Text] [Related]
18. Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients: A Retrospective Cohort Study at a Single Transplant Institute in Japan. Ishida H; Furusawa M; Unagami K; Omoto K; Iizuka J; Takagi T Exp Clin Transplant; 2022 May; 20(5):463-471. PubMed ID: 35607795 [TBL] [Abstract][Full Text] [Related]
19. Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients. Crane C; Phebus E; Ingulli E Pediatr Nephrol; 2022 Feb; 37(2):449-453. PubMed ID: 34522992 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Correlation Between Responders and Non-Responders to the Second Coronavirus Disease Vaccination In Kidney Transplant Recipients: A Retrospective Single-Center Cohort Study. Matsunami M; Suzuki T; Sugihara S; Toishi T; Nagaoka K; Fukuda J; Ohara M; Takanashi Y; Ochi A; Yashima J; Kuji H; Matsue K Transplant Proc; 2022; 54(6):1483-1488. PubMed ID: 35868872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]